Opportunity
Notice of Intent to Sole Source - Millipore Sigma
Response due
August 22, 2026
- Agency
- CDC Office of Acquisition Services
- Estimated value
- Not stated
2-day training with a specialist, including assay and instrument training as well as troubleshooting guidelines. Support- Assay specific technical support as well as Luminex instrumentation support. Description of End Products/Deliverables The FLEXMAP 3D instrument with xPONENT 4.3 Software. • Flexmap3D Unit (includes Analyzer, XYP plate handler) • PC bearing xPONENT 4.3 and Windows 10 • Flat Screen monitor • Keyboard and mouse • Power cables • USB Communication cables • Off plate reagent area • Automated Maintenance Plate (AMP) 96 & 384 well heater block
Key dates
- Posted
- August 20, 2026
- Response due
- August 22, 2026
Who is this buyer
Organization
Buying history
- Records110 total
- Opportunities / awards1 / 49
- Value range$0 – $290,871,939
- ActiveJuly 15, 2026 – October 26, 2026
What they buy
- Clinical (90)
- Administrative (18)
- Insurance (2)
Set-asides used
- No Set aside used (45)
- Small Business Set Aside - Total (4)
- Small Business Set Aside - Partial (1)
Who holds their work today
- WALGREEN CO.1 win · $290,871,939 · last June 14, 2022
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1 win · $186,198,497 · last September 29, 2022
- NEW YORK CITY HEALTH AND HOSPITALS CORPORATION2 wins · $133,057,936 · last September 26, 2025
- THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK1 win · $85,117,198 · last September 29, 2022
- CITY OF NEW YORK FIRE DEPARTMENT1 win · $70,314,507 · last September 29, 2022
Also open from this buyer
- Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032Due November 8, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 334516
- PSC
- 6640